Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases

M. Stelt, van der, H.H. Hansen, W.B. Veldhuis, P.R. Baer, K. Nicolaij, G.A. Veldink, J.F.G. Vliegenthart, H.S. Hansen

    Research output: Contribution to journalArticleAcademicpeer-review

    18 Citations (Scopus)
    2 Downloads (Pure)


    Endocannabinoids are thought to function as retrograde messengers, which modulate neurotransmitter release by activating presynaptic cannabinoid receptors. Anandamide and 2-arachidonoylglycerol (2-AG) are the two best studied endogenous lipids which can act as endocannabinoids. Together with the proteins responsible for their biosynthesis, inactivation and the cannabinoid receptors, these lipids constitute the endocannabinoid system. This system is proposed to be involved in various neurodegenerative diseases such as Parkinson's and Huntington's diseases as well as Multiple Sclerosis. It has been demonstrated that the endocannabinoid system can protect neurons against glutamate excitotoxicity and acute neuronal damage in bothin vitro andin vivo models. In this paper we review the data concerning the involvement of the endocannabinoid system in neurodegenerative diseases in which neuronal cell death may be elicited by excitotoxicity. We focus on the biosynthesis of endocannabinoids and on their modes of action in animal models of these neurodegenerative diseases.
    Original languageEnglish
    Pages (from-to)183-200
    JournalNeurotoxicity Research
    Issue number3
    Publication statusPublished - 2003


    Dive into the research topics of 'Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases'. Together they form a unique fingerprint.

    Cite this